CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L951. A total of 4 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | -98.5% | 2,600 | -92.0% | 0.00% | – |
| Q1 2023 | $136 | +134.5% | 32,400 | +230.6% | 0.00% | – |
| Q4 2022 | $58 | -99.9% | 9,800 | -45.9% | 0.00% | – |
| Q3 2022 | $105,000 | -36.4% | 18,100 | -34.7% | 0.00% | – |
| Q2 2022 | $165,000 | -38.7% | 27,700 | -52.0% | 0.00% | – |
| Q1 2022 | $269,000 | +26800.0% | 57,700 | +9516.7% | 0.00% | – |
| Q4 2021 | $1,000 | -98.6% | 600 | -97.8% | 0.00% | – |
| Q3 2021 | $69,000 | +3.0% | 26,900 | 0.0% | 0.00% | – |
| Q2 2021 | $67,000 | 0.0% | 26,900 | +11545.0% | 0.00% | – |
| Q1 2021 | $67,000 | – | 231 | +788.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 26 | -49.0% | 0.00% | – |
| Q3 2020 | $10,000 | – | 51 | +5000.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 1 | -97.9% | 0.00% | – |
| Q2 2019 | $4,000 | -50.0% | 47 | -43.4% | 0.00% | – |
| Q1 2019 | $8,000 | -61.9% | 83 | -15.3% | 0.00% | – |
| Q3 2018 | $21,000 | – | 98 | +988.9% | 0.00% | – |
| Q1 2017 | $0 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 300 | $1,000 | 0.00% |
| SIMPLEX TRADING, LLC | 26 | $0 | 0.00% |